SDGR SCHRODINGER INC
2026Q1 · CUSIP 80810D103 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
226
Δ holders QoQ
+4
Breadth percentile
Top 46%
Whale holders
121
Δ whales
+11
Inst. holding value
$746M
New positions
50
Closed positions
46
Price momentum (1Q)
+3.6%
Put / Call
7/6
Breadth history (34 quarters)
Past Lit Events & Aftermath 5 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2023Q2 | Top 2% | -12.8% | -14.4% |
| 2023Q1 | Top 15% | +19.4% | +8.9% |
| 2020Q4 | Top 11% | -44.6% | -48.2% |
| 2020Q3 | Top 14% | +72.0% | +7.8% |
| 2020Q2 | Top 6% | -14.5% | +55.3% |
Options Sentiment
Put holders
7
QoQ: +1
Call holders
6
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.40
EPS YoY
—
Revenue (TTM)
$0.3B
Revenue YoY
+10.6%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)